KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

AbbVie (ABBV) Interest & Investment Income (2016 - 2025)

Historic Interest & Investment Income for AbbVie (ABBV) over the last 14 years, with Q3 2025 value amounting to -$667.0 million.

  • AbbVie's Interest & Investment Income fell 1285.96% to -$667.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.6 billion, marking a year-over-year decrease of 3392.12%. This contributed to the annual value of -$2.2 billion for FY2024, which is 2826.6% down from last year.
  • Latest data reveals that AbbVie reported Interest & Investment Income of -$667.0 million as of Q3 2025, which was down 1285.96% from -$678.0 million recorded in Q2 2025.
  • Over the past 5 years, AbbVie's Interest & Investment Income peaked at -$378.0 million during Q4 2023, and registered a low of -$678.0 million during Q2 2025.
  • Moreover, its 5-year median value for Interest & Investment Income was -$539.0 million (2022), whereas its average is -$539.2 million.
  • Per our database at Business Quant, AbbVie's Interest & Investment Income surged by 2058.82% in 2023 and then plummeted by 6137.57% in 2024.
  • AbbVie's Interest & Investment Income (Quarter) stood at -$571.0 million in 2021, then increased by 16.64% to -$476.0 million in 2022, then rose by 20.59% to -$378.0 million in 2023, then tumbled by 61.38% to -$610.0 million in 2024, then dropped by 9.34% to -$667.0 million in 2025.
  • Its last three reported values are -$667.0 million in Q3 2025, -$678.0 million for Q2 2025, and -$627.0 million during Q1 2025.